From chemist to pharmacist and beyond …
Centenarian and PSA life member JSD ‘Stan’ Mellick OAM, ED, PhC, BA, PhD reflects on a 75-year association with pharmacy.
Should cannabidiol be down-scheduled to S3?
The Therapeutic Goods Administration (TGA) has delivered an interim decision to down-schedule low dose cannabidiol.
Antibiotic prescribing is reaching dangerous levels, warns report
Antibiotic use has crept back up since COVID-19 restrictions have lifted, with multi-resistant bugs increasingly in our midst.
Missing conversations
Patients are being harmed because we are not talking about the adverse effects of mental health medicines.
Top five pharmacy Budget asks
The PSA has provided a blueprint to help Federal Treasurer Jim Chalmers improve primary care and enhance medicine safety for all Australians.
Early intervention through HMRs could save thousands per patient
Greater access to Home Medicines Reviews (HMRs) offers opportunities to intervene earlier, improve patient outcomes and use healthcare funding more effectively.
